France Share Prices, Markets & Company News

Cac 40 Index 5,046.20+0.6%

SBF 120 Index 3,996.70+0.6%

BEL 20 Index 3,768.85+0.8%

Euronext 100 Index 974.25+0.6%

French Stock Search

Look up Euronext Paris Stocks, Markets, News, Forex and more

Orange

14.69
-0.095
-0.64%

EDF

7.64
-0.012
-0.16%

Total

46.42
+0.29
+0.63%

Loreal

178.70
-0.80
-0.45%

CAC 40

5,046.20
+28.77
+0.57%

SBF 120

3,996.70
+23.89
+0.60%

Euronext 100

974.25
+5.83
+0.60%

BEL 20

3,768.85
+29.31
+0.78%

EURONEXT Paris Share Prices

Name Price Change %
Total46.415+0.63%
Sanofi83.94+0.56%
Bnp Paribas61.92+2.58%
Engie12.725+0.99%
Orange14.685-0.64%
Societe Generale Eur1.2547.575+0.94%
Air Liquide106.20-0.23%
Carrefour21.76+0.23%
Danone63.31-1.39%
LVMH201.45-0.05%
Vivendi17.41+0.66%
Schneider Electric66.73+0.59%
AXA23.875+0.72%
Arcelormittal7.752+2.03%
L-Oreal178.70-0.45%
Vinci73.93-0.56%
Unibail-Rodamco215.20-1.15%
Saint Gobain46.67+1.46%
Pernod Ricard108.80+0.88%
Credit Agricole12.71+3.80%
Essilor113.85+0.40%
Michelin111.70+0.59%
EDF7.635-0.16%
Kering238.55+0.74%
Alstom27.095-0.17%
Airbus Eur170.83+2.16%
Renault81.78+1.46%
Vallourec SA Eur2.005.67+6.18%
Veolia17.05+0.47%
Bouygues38.25+0.16%

Euro FOREX Rates

More FOREX
Divisas Price Change
EUR USD1.0811-0.0005
EUR JPY120.2355+0.0905
EUR GBP0.8681+0.0001
EUR AUD1.4163+0.0006
EUR CHF1.0730+0.0002
EUR CAD1.4468+0.0001
EUR HKD8.3981-0.0037
EUR SEK9.5521+0.0053
EUR NZD1.5431+0.0019
EUR KRW1,206.0500-0.3000
EUR SGD1.5120+0.0016

Commodities Prices

More Commodities
Name Market Price %
GoldCOMEX1,250.50-0.07%
SilverCOMEX18.17-0.27%
PlatinumNYMEX957.00-0.15%
CopperCOMEX2.67+0.11%
Brent Crude OilNYMEX51.39+0.14%
GasolineNYMEX1.63+0.18%
Natural GasNYMEX3.17-0.19%
RubberTOCOM240.90+0.00%

French Market News

More Market News

FDA Approves Regeneron and Sanofi's Dupixent for Eczema -- Update

By Joseph Walker Regeneron Pharmaceuticals Inc. and Sanofi SA said they would charge $37,000 annually in the U.S. for their newly approved eczema drug, a price the companies said they reached after months of negotiations with pharmacy-benefit managers. The Food and Drug Administration approved the drug, called Dupixent, for U.S. sale on Tuesday. Through their negotiations, the companies said they aimed to set a price the pharmacy-benefit managers, or...

12:26FDA Approves Regeneron and Sanofi's Dupixent for Eczema
07:24Akzo Nobel to Detail Plan to Separate Its Specialty Chemicals Business -- Update
03:01Akzo Nobel to Reveal Plans to Split Business April 19
01:56Philips to Buy Australian pharmacy Sleep Services Firm
19:44Foreign Investors Flock to Iran as U.S. Firms Watch on the Sidelines -- Update
11:10Total to Invest $1.7 Billion to Expand Petrochemicals Activities in Texas
05:59Foreign Investors Flock to Iran as U.S. Firms Watch on the Sidelines
04:28Smiths Group 1st Half Pretax Profit More Than Doubles
14:20Akzo Nobel's Largest Shareholder Urges Engagement With PPG -- 2nd Update
Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:43 V: D:20170328 23:34:16